Brief: Jazz Pharmaceuticals Q1 Adjusted EPS USD 1.68 Vs. IBES Estimate USD 4.66
06/05/2025 21:05
May 06 (Reuters) - Jazz Pharmaceuticals Q1 revenue USD 897.841 million vs. IBES estimate USD 985.4 million. Q1 EPS USD -1.52 Q1 net income USD -92.541 million Q1 adjusted net income USD 105.233 million vs. IBES estimate USD 288.6 million
Recent news on Jazz Pharmaceuticals
See all newsBrief: Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Jazz Pharma dips after upsized $1.1 bln convertible offering
Brief: Jazz Pharmaceuticals Announces Private Offering Of $1.0 Billion Of Exchangeable Senior Notes Due 2032